Skip to main content

Advertisement

Table 1 Patient’s characteristics according to the presence or absence of Metabolic Syndrome

From: Metabolic syndrome is associated with advanced prostate cancer in patients treated with radical retropubic prostatectomy: results from a multicentre prospective study

  Overall No MetS MetS p
Patients (%) 349 262/349 (75 %) 87/349 (25 %)  
Age, years 64.5 ± 6.09 (66;61/69) 64.05 ± 6.53 (65;59/69) 64.92 ± 4.87 (65;62/68) 0.473
BMI, kg/m2 27.4 ± 12.77 (26.12;24/29) 26.56 ± 3.69 (26;24/28.4) 28.64 ± 3.45 (28;26.3/30.57) <0.001
PSA, ng/ml 9.87 ± 11.84 (7.07;5.08/10) 10.41 ± 12.28 (7.11;5.1/9.8) 10.80 ± 16.75 (8.18;4.39/11.95) 0.687
TRUS Volume, ml 53.07 ± 29.59 (48;35.1/60) 55.43 ± 34 (47.75;36/60) 53.4 ± 24.01 (50;37/67) 0.661
Waist, cm 99.51 ± 9.85 (99;94/106) 98.87 ± 9.45 (98;93/105) 102.77 ± 11.3 (102.5;96/110) 0.009
Glycemia, mg/dl 101.86 ± 23.42 (96;88/108) 98.48 ± 19.15 (94;87/104) 113.19 ± 25.7 (111;97/111) 0.003
Triglyceridemia, mg/dl 131.8 ± 64.4 (115;83.7/161.2) 126.07 ± 58 (110;83/155) 152.11 ± 78.88 (133;87/199.5) 0.040
HDL, mmol/l 51.8 ± 14.06 (50;42/59) 52.87 ± 13.44 (51;43/60) 47.72 ± 15.9 (45;36.5/57) 0.023
Hypertension 182/349 (52 %) 113/262 (43 %) 69/87 (79 %) <0.001
  1. Data are presented as mean ± SD (median; IQR)